Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis

Detalles Bibliográficos
Autores principales: Gao, Ming, Ao, Guangyu, Hao, Xiaodan, Xie, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155463/
https://www.ncbi.nlm.nih.gov/pubmed/37146726
http://dx.doi.org/10.1016/j.jinf.2023.04.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155463/
https://www.ncbi.nlm.nih.gov/pubmed/37146726
http://dx.doi.org/10.1016/j.jinf.2023.04.019

Ejemplares similares